New Dental Drug Reference From Mosby
Mosby, Inc, has just released the 8th edition of its Dental Drug Reference, now complete with comprehensive drug, herb, and supplement monographs contributed by members of the Natural Standard Research Collaboration including Drs. Catherine Ulbricht and Erica Seamon.
Mosby's Dental Drug Reference contains 870 clear and concise monographs on dosing, usage, contraindications, pregnancy risks, mechanism of action, adverse effects, vital classifications, and precautions for each drug, as well as special considerations specific to dentistry. Additionally, this 8th edition includes brand new drugs that have just recently been approved by the FDA. Mosby's Dental Drug Reference also counsels dentists on drugs that are most clinically significant and includes all dentistry related interactions that could potentially occur. The purpose of this reference is to serve as a quick and logical resource to assist dentists in making clinical decisions and consultations.
Information is arranged in a user-friendly format that can be utilized at-a-glance and the portable pocket size of the reference provides office and travel versatility. In order to improve patient communication, Mosby's Dental Drug Reference is accompanied by a CD containing full color illustrations of drug-related pathologic conditions, a pill atlas, a glossary of terms, and patient handouts in both English and Spanish. The appendices include abbreviations, anesthetics, combination products, controlled substances, disorders and conditions, therapeutic management of oral lesions, drugs of abuse, drug use in pediatric dentistry, and herbal and non-herbal remedies.
To maintain the most current information, a supplemental website updated with relative information released post-publication is available through Evolve Resources (http://evolve.elsevier.com). Mosby's Dental Drug Reference is currently available at http://elsevierhealth.com.
Mosby's Dental Drug Reference contains 870 clear and concise monographs on dosing, usage, contraindications, pregnancy risks, mechanism of action, adverse effects, vital classifications, and precautions for each drug, as well as special considerations specific to dentistry. Additionally, this 8th edition includes brand new drugs that have just recently been approved by the FDA. Mosby's Dental Drug Reference also counsels dentists on drugs that are most clinically significant and includes all dentistry related interactions that could potentially occur. The purpose of this reference is to serve as a quick and logical resource to assist dentists in making clinical decisions and consultations.
Information is arranged in a user-friendly format that can be utilized at-a-glance and the portable pocket size of the reference provides office and travel versatility. In order to improve patient communication, Mosby's Dental Drug Reference is accompanied by a CD containing full color illustrations of drug-related pathologic conditions, a pill atlas, a glossary of terms, and patient handouts in both English and Spanish. The appendices include abbreviations, anesthetics, combination products, controlled substances, disorders and conditions, therapeutic management of oral lesions, drugs of abuse, drug use in pediatric dentistry, and herbal and non-herbal remedies.
To maintain the most current information, a supplemental website updated with relative information released post-publication is available through Evolve Resources (http://evolve.elsevier.com). Mosby's Dental Drug Reference is currently available at http://elsevierhealth.com.
Comments